Dendrimer nanocomposites for cancer therapy

Nanotechnology for Cancer Therapy

Volumn , Issue , 2006, Pages 551-592

  Balogh, Lajos P ^a   Khan, Mohamed K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85132540531     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (124)

1. Alivisatos, A. P. and Schultz, P. G., Organization of 'nanocrystal molecules' using DNA, Nature, 382 (6592), 609-611, 1996.
2. Schmid, G., Large clusters and colloids. Metals in the embryonic state, Chem. Rev., 92(8), 1709-1727, 1992.
3. Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., and Thun, M. J., Cancer statistics, CA Cancer J. Clin., 54(1), 8-29, 2004.
4. Khan, M. K., Nigavekar, S. S., Minc, L. D., Kariapper, M. S., Nair, B. M., Lesniak, W. G., and Balogh, L. P., In vivo biodistribution of dendrimers and dendrimer nanocomposites-implications for cancer imaging and therapy, Technol. Cancer Res. Treat., 4 (6), 603-613, 2005.
5. Bielinska, A., Eichman, J. D., Lee, I., Baker, J. R., and Balogh, L., Imaging gold-dendrimer nanocomposites in cells, J. Nanopart. Res., 4, 395-403, 2002.
6. Grohn, F., Bauer, B. J., Akpalu, Y. A., Jackson, C. L., and Amis, E. J., Dendrimer templates for the formation of gold nanoclusters, Macromolecules, 33(16), 6042-6050, 2000.
7. McDevitt, M. R., Ma, D., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., and Miederer, M., et al., Tumor therapy with targeted atomic nanogenerators, Science, 294 (5546), 1537-1540, 2001.
8. Newkome, G. R., Moorefield, C. N., and Vogtle, F., Eds., Dendritic Macromolecules: Concepts, Syntheses, Perspectives, Wiley-VCH, New York, 1996.
9. Frechet, J. M. J. and Tomalia, D. A., Eds., Dendrimers and Other Dendritic Polymers, Wiley, New York, p. 647, 2001.
10. Mansfield, M. L. and Klushin, L. I., Monte Carlo studies of dendrimer macromolecules, Macro-molecules, 26 (16), 4262-4268, 1993.
11. Karatasos, K., Adolf, D. B., and Davies, G. R., Statics and dynamics of model dendrimers as studied by molecular dynamics simulation, J. Chem. Phys., 115, 5310-5318, 2001.
12. Murat, M. and Grest, G. S., Molecular dynamics study of dendrimer molecules in solvents of varying quality, Macromolecules, 29(A), 1278-1285, 1996.
13. Welch, P. and Muthukumar, M., Tuning the density profile of dendritic polyelectrolytes, Macro-molecules, 31(17), 5892-5897, 1998.
14. Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., and Smith, P., Polym. J. (Tokyo), 17 (1), 117-132, 1985.
15. Grayson, S. M. and Frechet, J. M. J., Convergent dendrons and dendrimers: From synthesis to applications, Chem. Rev., 101 (12), 3819-3868, 2001.
16. Duncan, R. and Izzo, L., Dendrimer biocompatibility and toxicity, Adv. Drug Deliv. Rev., 57(15), 2215-2237, 2005.
17. Roberts, J. C., Bhalgat, M. K., and Zera, R. T., Preliminary biological evaluation of polyamidoamine (PAMAM) starburst dendrimers, J. Biomed. Mater. Res., 30 (1), 53-65, 1996.
18. Tomalia, D. A., Dewald, J. R., Hall, M. J., Martin, S.J., and Smith, P. B., First SPSJ International Polymer Conference, Kyoto, Japan, p. 65, 1984.
19. Tomalia, D. A., Naylor, A. M., and Goddard, W. A., Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter, Angew. Chem. Int. Ed. Engl., 29(2), 138-175, 1990.
20. D'Emanuele, A. and Attwood, D., Dendrimer-drug interactions, Adv. Drug Deliv. Rev., 57(15), 2147-2162, 2005.
21. Svenson, S. and Tomalia, D. A., Dendrimers in biomedical applications-reflections on the field, Adv. Drug. Deliv. Rev., 57 (15), 2106-2129, 2005.
22. Tomalia, D. A. and Dvornic, P. R., In Polymeric Materials Encyclopedia, Salamone, J. C., Ed., Vol. 3, CRC Press, Boca Raton, FL, pp. 1814-1830, 1996.
23. Bielinska, A., Kukowska-Latallo, J. F., Johnson, J., Tomalia, D. A., and Baker, J. R. Jr., Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids trans-fected using starburst PAMAM dendrimers, Nucleic Acids Res., 24 (11), 2176-2182, 1996.
24. El-Sayed, M., Kiani, M. F., Naimark, M. D., Hikal, A. H., and Ghandehari, H., Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium, Pharm. Res., 18 (1), 23-28, 2001.
25. Malik, N., Evagorou, E. G., and Duncan, R., Dendrimer-platinate: Anovel approach to cancer chemotherapy, Anticancer Drugs, 10(8), 767-776, 1999.
26. Raduchel, B., Schmitt-Willich, S., Ebert, J., Frezel, T., Misselwitz, B., and Weinmann, H. J., Synthesis and Characterization of Novel Dendrimer-Based Gadolinium Complexes as MRI Contrast Agents for the Vascular System, American Chemical Society, Washington, DC, p. 278, 1998.
27. Wilbur, D. S., Pathare, P. M., Hamlin, D. K., Buhler, K. R., and Vessella, R. L., Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendri-mers, Bioconjug. Chem., 9 (6), 813-825, 1998.
28. Shi, X., Banyai, I., Islam, M. T., Lesniak, W., Davis, D. Z., Baker, J. R. J., and Balogh, L. P., Generational, skeletal and substitutional diversities in generation one poly(amidoamine) dendrimers, Polymer, 46, 3022-3034, 2005.
29. Uppuluri, S., Swanson, D. R., Brothers, H. M., Piehler, L. T., Li, J., Meier, D. J., Hagnauer, G. L., and Tomalia, D. A., Tecto(dendrimer) core-shell molecules: Macromolecular tectonics for the systemic synthesis of larger controlled structure molecules, Polym. Mater. Sci. Eng., 80, 55-56, 1999.
30. Uppuluri, S., Swanson, D. R., Brothers, H. M. I., Piehler, L. T., Li, J., Meier, D. J., H., G. L., Tomalia, D.A, Core-Shell Tecto(Dendrimers): ANew Class of Regio-Specifically Cross-Linked Polymers, Polymers for Advanced Technologies (PAT), Tokyo, Japan, August 31-September 5, pp. 94-95, 1999.
31. Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mule, J., and Baker, J. R. Jr., Design and function of adendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor, Pharm. Res., 19 (9), 1310-1316, 2002.
32. Balogh, L., Swanson, D.R., Spindler, R., Tomalia., D.A., Formation and characterization of dendrimer-based water soluble inorganic nanocomposites, In Proceedings of the American Chemical Society, Division of Polymeric Materials Science and Engineering, Vol. 77, Los Vegas, VV, pp. 118-119, 1997.
33. Tan, N. B., Balogh, L., and Trevino, S., Structure of metallo-organic nanocomposites produced from dendrimer complexes, Proc. ACS Polym. Mater.: Sci. Eng., 77, 120, 1997.
34. Balogh, L. and Tomalia, D. A., Dendrimer-templated nanocomposites. I. Synthesis of zero-valent copper nanoclusters, J. Am. Chem. Soc., 120, 7355-7356, 1998.
35. Zhao, M., Sun, L., and Crooks, R. M., Preparation of Cu nanoclusters within dendrimer templates, J. Am. Chem. Soc., 120 (19), 4877-4878, 1998.
36. Esumi, K., Suzuki, A., Aihara, N., Usui, K., and Torigoe, K., Preparation of gold colloids with UV irradiation using dendrimers as stabilizer, Langmuir, 14(12), 3157-3159, 1998.
37. Larre, C., Donnadieu, B., Caminade, A. M., and Majoral, J. P., Regioselective gold complexation within the cascade structure of phosphorus-containing dendrimers, Chem. Eur. J., 4 (10), 2031-2036, 1998.
38. Bosman, A. W., Janssen, H. M., and Meijer, E. W., About dendrimers: Structure, physical properties, and applications, Chem. Rev., 99, 1665-1688, 1999.
39. Diallo, M., Balogh, L., Shafagati, A., Johnson, J. H. J., Goddard, W. A. I., and Tomalia, D. A., 2-Poly(amidoamine) dendrimers: Anew class of high capacity chelating agents for Cu (II) ions, Environ. Sci. Technol., 33(5), 820-824, 1999.
40. Diallo, M. S., Christie, S., Swaminathan, P., Balogh, L., Shi, X., Um, W., Papelis, C., Goddard, W. A. III, and Johnson, J. H. Jr., Dendritic chelating agents. 1. Cu(II) binding to ethylene diamine core poly(amidoamine) dendrimers in aqueous solutions, Langmuir, 20(7), 2640-2651, 2004.
41. Balogh, L., Valuzzi, R., Laverdure, K. S., Gido, S. P., Hagnauer, G. L., and Tomalia, D. A., Formation of silver and gold dendrimer nanocomposites, J. Nanopart. Res., 1(3), 353-368, 1999.
42. Balogh, L., Laverdure, K. S. Gido, S. P., Mott A. G., Miller, M. J., Ketchel, B. P., Tomalia, D. A. Dendrimer-metal nanocomposites, In Organic/Inorganic Hybrid Materials, pp. 69-75, 1999.
43. Hong, S., Bielinska, A. U., Mecke, A., Keszler, B., Beals, J. L., Shi, X., Balogh, L., Orr, B. G., Baker, J. R. Jr., and Banaszak Holl, M. M., Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: Hole formation and the relation to transport, Bioconjug. Chem., 15(4), 774-782, 2004.
44. Martin, C. R., Science, 266, 1961-1966, 1994.
45. Shaw, C. F. III, Gold-based therapeutic agents, Chem. Rev., 99, 2589-2600, 1999.
46. El-Sayed, I. H., Huang, X., and El-Sayed, M. A, Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles, Cancer Lett., 2005.
47. Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, N. J., and West, J. L., Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance, Proc. Natl Acad Sci. U.S.A., 100 (23), 13549-13554, 2003.
48. Loo, C., Lowery, A., Halas, N., West, J., and Drezek, R., Immunotargeted nanoshells for integrated cancer imaging and therapy, Nano Lett., 5 (4), 709-711, 2005.
49. Loo, C., Lin, A., Hirsch, L., Lee, M., Barton, J., Halas, N., West, J., and Drezek, R., Nanoshell-enabled photonics-based imaging and therapy of cancer, Technol. Cancer Res. Treat., 3, 33-40, 2004.
50. Holm, H. H. III, The history of interstitial brachytherapy of prostatic cancer, Semin. Surg. Oncol., 13, 431-437, 1997.
51. Root, S. W., Andrews, G. A., Knieseley, R. M., and Tyor, M. P., The distribution and radiation effects of intravenously administered colloidal Au 198 in man, Cancer, 7, 856-866, 1954.
52. Rubin, P. and Levitt, S. H., The response of disseminated reticulum cell sarcoma to the intravenous injection of colloidal radioactive gold, J. Nucl. Med., 5, 581-594, 1964.
53. Flocks, R. H., Kerr, H. D., Elkins, H. B., and Culp, A., Treatment of carcinoma of the prostate by interstitial radiation with radio-active gold: Apreliminary report, J. Urol., 68, 510-522, 1952.
54. Loening, S. A., Gold seed implantation in prostate brachytherapy, Semin. Surg. Oncol., 13(6), 419-424, 1997.
55. Hainfeld, J. F., Foley, C. J., Srivastava, S. C., Mausner, L. F., Feng, N. I., Meinken, G. E., and Steplewski, Z., Radioactive gold cluster immunoconjugates: Potential agents for cancer therapy, Int. J. Radiat. Appl. Instrum. Part B, Nucl. Med. Biol. (Oxford), 17 (3), 287-294, 1990.
56. Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., and Tamarkin, L., Colloidal gold: Anovel nanoparticle vector for tumor directed drug delivery, Drug Deliv., 11(3), 169-183, 2004.
57. Garcia, M. E., Baker, L. A., and Crooks, R. M., Preparation and characterization of dendrimer-gold colloid nanocomposites, Anal. Chem., 71 (1), 256-258, 1999.
58. Tomalia, D. A., Balogh, L. P., US Patent No. 6, 664, 315B2, 2003.
59. Balogh, L., Tomalia, D. A., and Hagnauer, G. L., Revolution of nanoscale proportions, Chem. Innovation, 30 (3), 19-26, 2000.
60. Ottaviani, M. F., Valluzzi, R., and Balogh, L., Internal structure of silver-poly(amidoamine) dendrimer complexes and nanocomposites, Macromolecules, 35(13), 5105-5115, 2002.
61. Balogh, L., Bielinska, A., Eichman, J. D., Valluzzi, R., Lee, I., Baker, J. R., Lawrence, T. S., and Khan, M. K., Dendrimer nanocomposites in medicine, Chim. Oggi (Chem. Today), 20(5), 35-40, 2002.
62. Cotton F. A., Willinson G., Advanced Inorganic Chemistry, 4 ed., Wiley, New York, pp. 1052-1055, 1980.
63. Lee, W. I., Bae, Y., and Bard, A. J., Strong blue photoluminescence and ECL from OH-terminated PAMAM dendrimers in the absence of gold nanoparticles, J. Am. Chem. Soc., 126, 8358-8359, 2004.
64. Esumi, K., Suzuki, A., Yamahira, A., and Torigoe, K., Role of poly(amidoamine) dendrimers for preparing nanoparticles of gold, platinum, and silver, Langmuir, 16(6), 2604-2608, 2000.
65. Balogh, L., Ganser, T. R., and Shi, X. In Characterization of Dendrimer-Gold Nanocomposite Materials, Materials Research Society Symposium Proceedings, Warrendale, PA, 2005; Sanchez, C., Schubert, U., Laine, R. M., Chujo, Y., Materials Research Society, Warrendale, PA, EE13.33, pp. 1-6, 2005.
66. Esumi, K., Dendrimers for nanoparticle synthesis and dispersion stabilization, Top. Curr. Chem., 227, 31-52, 2003.
67. Seo, Y.-S., Kim, K. S., Shin, K., White, H., Rafailovich, M., Sokolov, J., Lin, B., Kim, H. J., Zhang, C., and Balogh, L., Morphology of amphiphilic gold/dendrimer nanocomposite monolayers, Langmuir, 18 (15), 5927-5932, 2002.
68. Tomalia, D. A., Baker, H., Dewald, J., Hall, M., and Kallos, G., Dendritic macromolecules: Synthesis of starburst dendrimers, Macromolecules, 19, 2466-2468, 1986.
69. Uppuluri, S., Swanson, D. R., Piehler, L. T., Li, J., Hagnauer, G. L., and Tomalia, D. A., Core-shell tecto(dendrimers): I. Synthesis and characterization of saturated shell models, Adv. Mater., 12(11), 796-800, 2000.
70. Li, J., Swanson, D. R., Qin, D., Brothers, H. M., Piehler, L. T., Tomalia, D., and Meier, D. J., Characterizations of core-shell tecto-(dendrimer) molecules by tapping mode atomic force microscopy, Langmuir, 15 (21), 7347-7350, 1999.
71. Tomalia, D. A., Piehler, L. T., Durst, H. D., and Swanson, D. R., Partial shell-filled core-shell tecto(dendrimers): Astrategy to surface differentiated nano-clefts and cusps, Proc. Natl Acad. Sci. U.S.A., 99 (8), 5081-5087, 2002.
72. Shi, X., Patri, A. K., Lesniak, W., Islam, M. T., Zhang, C., Baker, J. R., and Balogh, L. P., Analysis of poly(amidoamine)-succinamic acid dendrimers by slab-gel electrophoresis and capillary zone electrophoresis, Electrophoresis, 26, 2960-2967, 2005.
73. Islam, M. T., Shi, X., Balogh, L. P., and Baker, J. R., HPLC separation of different generations of poly(amidoamine) dendrimers modified with various terminal groups, Anal. Chem., 77, 2063-2070, 2005.
74. Shi, X., Lesniak, W., Islam, M. T., Muniz, M. C., Balogh, L. P., and Baker, J. R., Comprehensive characterization of surface-functionalized poly(amidoamine) dendrimers with acetamide, hydroxyl, and carboxyl groups, Colloids Surf., A: Physicochem. Eng. Aspects, 272, 139-150, 2006.
75. Shi, X., Banyai, I., Islam, M. T., Lesniak, W., Davis, D. Z., Baker, J. R., and Balogh, L. P., Generational, skeletal and substitutional diversities in generation one poly(amidoamine) dendrimers, Polymer, 46(9), 3022-3034, 2005.
76. Lesniak, W., Bielinska, A. U., Sun, K., Janczak, K. W., Shi, X., Baker, J. R., and Balogh, L. P., Silver/dendrimer nanocomposites as biomarkers: Fabrication, characterization, in vitro toxicity, and intracellular detection, Nano Lett., 5 (11), 2123-2130, 2005.
77. Nigavekar, S. S., Sung, L. Y., Llanes, M., El-Jawahri, A., Lawrence, T. S., Becker, C. W., Balogh, L., and Khan, M. K., 3H dendrimer nanoparticle organ/tumor distribution, Pharm. Res., 21 (3), 476-483, 2004.
78. Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., and Duncan, R., Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo, J. Control. Release, 65 (1-2), 133-148, 2000.
79. Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., and Baker, J. R. Jr., Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer, Cancer Res., 65(12), 5317-5324, 2005.
80. Tang, M. X., Redemann, C. T., and Szoka, F. C., In vitro gene delivery by degraded polyamidoamine dendrimers, Bioconjug. Chem., 7, 703-714, 1996.
81. Rosi, N. L. and Mirkin, C. A., Nanostructures in biodiagnostics, Chem. Rev., 105, 1547-1562, 2005.
82. Burda, C., Chen, X., Narayanan, R., and El-Sayed, M. A., Chemistry and properties of nanocrystals of different shapes, Chem. Rev., 105, 1025-1102, 2005.
83. Bonkhoff, H. and Remberger, K., Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate, Virchows Arch. APathol. Anat. Histo-pathol., 422 (1), 35-38, 1993.
84. Pasqualini, R. and Ruoslahti, E., Organ targeting in vivo using phage display peptide libraries, Nature, 380 (6572), 364-366, 1996.
85. Rajotte, D. and Ruoslahti, E., Membrane dipeptidase is the receptor for alung-targeting peptide identified by in vivo phage display, J. Biol. Chem., 274 (17), 11593-11598, 1999.
86. Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R. A., Shapiro, L. H., Arap, W., and Ruoslahti, E., Aminopeptidase Nisareceptor for tumor-homing peptides and atarget for inhibiting angiogenesis, Cancer Res., 60(3), 722-727, 2000.
87. Arap, W., Pasqualini, R., and Ruoslahti, E., Cancer treatment by targeted drug delivery to tumor vasculature in amouse model, Science, 279 (5349), 377-380, 1998.
88. Pasqualini, R., Koivunen, E., and Ruoslahti, E., Alpha vintegrins as receptors for tumor targeting by circulating ligands, Nat. Biotechnol., 15 (6), 542-546, 1997.
89. Burg, M. A., Pasqualini, R., Arap, W., Ruoslahti, E., and Stallcup, W. B., NG2 proteoglycan-binding peptides target tumor neovasculature, Cancer Res., 59 (12), 2869-2874, 1999.
90. Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., and Krajewski, S., Anti-cancer activity of targeted pro-apoptotic peptides, Nat. Med., 5 (9), 1032-1038, 1999. http:// www.java/Propub/medicine/nm0999_1032.fulltextjava/Propub/medicine/nm0999_1032.abstract.
91. Dmitriev, I., Krasnykh, V., Miller, C. R., Wang, M., Kashentseva, E., Mikheeva, G., Belousova, N., and Curiel, D. T., An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of acoxsackievirus and adenovirus receptor-independent cell entry mechanism, J. Virol., 72 (12), 9706-9713, 1998.
92. DeNardo, S. J., Burke, P. A., Leigh, B. R., O'Donnell, R. T., Miers, L. A., Kroger, L. A., and Goodman, S. L., Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy, Cancer Biother. Radiopharm., 15 (1), 71-79, 2000.
93. Janssen, M. L., Oyen, W. J., Dijkgraaf, I., Massuger, L. F., Frielink, C., Edwards, D. S., Rajopadhye, M., Boonstra, H., Corstens, F. H., and Boerman, O. C., Tumor targeting with radiolabeled alpha(v)-beta(3) integrin binding peptides in anude mouse model, Cancer Res., 62 (21), 6146-6151, 2002.
94. Ogawa, M., Hatano, K., Oishi, S., Kawasumi, Y., Fujii, N., Kawaguchi, M., Doi, R., Imamura, M., Yamamoto, M., Ajito, K. et al., Direct electrophilic radiofluorination of acyclic RGD peptide for in vivo alpha(v)beta(3) integrin related tumor imaging(1), Nucl. Med. Biol., 30 (1), 1-9, 2003.
95. Haubner, R., Wester, H. J., Weber, W. A., Mang, C., Ziegler, S. I., Goodman, S. L., Senekowitsch-Schmidtke, R., Kessler, H., and Schwaiger, M., Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography, Cancer Res., 61 (5), 1781-1785, 2001.
96. Sivolapenko, G. B., Skarlos, D., Pectasides, D., Stathopoulou, E., Milonakis, A., Sirmalis, G., Stuttle, A., Courtenay-Luck, N. S., Konstantinides, K., and Epenetos, A. A., Imaging of metastatic melanoma utilising atechnetium-99m labelled RGD-containing synthetic peptide, Eur. J. Nucl. Med., 25 (10), 1383-1389, 1998.
97. Liu, S., Edwards, D. S., Ziegler, M. C., Harris, A. R., Hemingway, S. J., and Barrett, J. A., 99mTc-labeling of ahydrazinonicotinamide-conjugated vitronectin receptor antagonist useful for imaging tumors, Bioconjug. Chem., 12 (4), 624-629, 2001.
98. Folkman, J., Tumor Angiogenesis, In Cancer Medicine, Holland, J. F., Bast, R. C., Morton, D. L., Frei, E., Kufe, D. W., and Weichselbaum, R. R., Eds., Vol. 1, Williams and Wilkens, Baltimore, MD, pp. 181-204, 1996.
99. Jain, R. K., Determinants of tumor blood flow: Areview, Cancer Res., 48 (10), 2641-2658, 1998.
100. Ribatti, D., Vacca, A., and Dammacco, F., The role of the vascular phase in solid tumor growth: A historical review, Neoplasia, 1(4), 293-302, 1999.
101. Schlingemann, R. O., Rietveld, F. J., Kwaspen, F., van de Kerkhof, P. C., de Waal, R. M., and Ruiter, D. J., Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue, Am. J. Pathol., 138 (6), 1335-1347, 1991.
102. Matsumura, Y. and Maeda, H., Anew concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res., 46(12 Pt 1), 6387-6392, 1986.
103. Duncan, R., Malik, N., Richardson, S., and Ferruti, P., Polymer conjugates for anti-cancer agent and DNA delivery, Polym. Prepr. (Am. Chem. Soc. Div., Polym. Chem.), 39, 180, 1998.
104. Muggia, F. M., Doxorubicin-polymer conjugates: Further demonstration of the concept of enhanced permeability and retention, Clin. Cancer Res., 5 (1), 7-8, 1999.
105. Hainfeld, J. F., Foley, C. J., Srivastava, S. C., Mausner, L. F., Feng, N. I., Meinken, G. E., and Steplewski, Z., Radioactive gold cluster immunoconjugates: Potential agents for cancer therapy, Int. J. Rad. Appl. Instrum. B, 17 (3), 287-294, 1990.
106. Sharma, V., Luker, G. D., and Piwnica-Worms, D., Molecular imaging of gene expression and protein function in vivo with PET and SPECT, J. Magn. Reson. Imaging, 16(4), 336-351, 2002.
107. Berning, D. E., Katti, K. V., Volkert, W. A., Higginbotham, C. J., and Ketring, A. R., 198Au-labeled hydroxymethyl phosphines as models for potential therapeutic pharmaceuticals, Nucl. Med. Biol., 25 (6), 577-583, 1998.
108. Brechbiel, M. W., Gansow, O. A., Wu, C., Garmestani, K., Yordanov, A., Deal, K., and Chappell, L., In Chelated Metal Ions for Therapeutic and Diagnostic Applications, 215th ACS Natioinal Meeting, Dallas, March 29-April 2, ACS, Washington, DC, Dallas, NUCL-106, 1998.
109. Wiener, E. C., Brechbiel, M. W., Brothers, H., Magin, R. L., Gansow, O. A., Tomalia, D. A., and Lauterbur, P. C., Dendrimer-based metal chelates: Anew class of magnetic resonance imaging contrast agents, Magn. Reson. Med., 31 (1), 1-8, 1994.
110. Wu, C., Brechbiel, M. W., Kozak, R. W., and Gansow, O. A., Metal-chelate-dendrimer-antibody constructs for use in radioimmunotherapy and imaging, Bioorg. Med. Chem. Lett., 4(3), 449-454, 1994.
111. Wiener, E. C., Konda, S., Shadron, A., Brechbiel, M., and Gansow, O., Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor, Investig. Radiol., 32(12), 748-754, 1997.
112. Brechbeil, M., J. Nucl. Med., 35(5suppl. S), 62, 1994.
113. Barth, R. F., Soloway, A. H., and Brugger, R. M., Boron neutron capture therapy of brain tumors: Past history, current status, and future potential, Cancer Investig., 14(6), 534-550, 1996.
114. Margerum, L. D., Campion, B. K., Koo, M., Shargill, N., Lai, J., Marumoto, A., and Sontum, P. C., J. Alloys Compd., 249 (1-2), 185-190, 1997.
115. Von Kleist, S., Ten years of tumor imaging with labelled antibodies, In Vivo, 7 (6B), 581-584, 1993.
116. Blankenberg, F. G. and Strauss, H. W., Nuclear medicine applications in molecular imaging, J. Magn. Reson. Imaging, 16(4), 352-361, 2002.
117. Kwekkeboom, D., Krenning, E. P., and de Jong, M., Peptide receptor imaging and therapy, J. Nucl. Med., 41 (10), 1704-1713, 2000.
118. Ang, E. S. and Sundram, F. X., Prospects for tumour imaging with radiolabelled antibodies, Ann. Acad. Med. Singapore, 22(5), 776-784, 1993.
119. Deshpande, S. V., DeNardo, S. J., Kukis, D. L., Moi, M. K., McCall, M. J., DeNardo, G. L., and Meares, C. F., Yttrium-90-labeled monoclonal antibody for therapy: Labeling by anew macrocyclic bifunctional chelating agent, J. Nucl. Med., 31 (4), 473-479, 1990.
120. Beaumier, P. L., Venkatesan, P., Vanderheyden, J. L., Burgua, W. D., Kunz, L. L., Fritzberg, A. R., Abrams, P. G., and Morgan, A. C. Jr., 186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice, Cancer Res., 51 (2), 676-681, 1991.
121. Chalandon, Y., Mach, J. P., Pelegrin, A., Folli, S., and Buchegger, F., Combined radioimmu-notherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations, Anticancer Res., 12 (4), 1131-1139, 1992.
122. Cheung, N. K., Landmeier, B., Neely, J., Nelson, A. D., Abramowsky, C., Ellery, S., Adams, R. B., and Miraldi, F., Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice, J. Natl Cancer Inst., 77(3), 739-745, 1986.
123. Esteban, J. M., Schlom, J., Mornex, F., and Colcher, D., Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: Histological and autoradiographic study of effects on tumors and normal organs, Eur. J. Cancer Clin. Oncol., 23(6), 643-655, 1987
124. Balogh, L. P., Nigavekar, S. S., Cook, A. C., Minc, L., and Khan, M. K., Development of dendrimer-gold radioactive nanocomposites to treat cancer microvasculature, PharmaChem, 2 (4), 94-99, 2003.